Teleflex Incorporated

TFX Healthcare Medical Instruments & Supplies

Teleflex Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 17.2% from fiscal 2024.

Revenue
+0.15%
EPS
+342.0%
Free cash flow
+220.1%
Total debt
−39.4%

Quarter to September 2026, against a year earlier

151.46 0.69 −0.45%
Market cap
$6.5B
P/E
18.2×
Fwd P/E
37.4×
Dividend yield
0.90%
F-score
5/9
Altman Z
2.04
Beneish M
−2.21
Dividend safety
20/100
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
Piotroski F-Score
7 6 6 5

+8 more TTM periods

ROE
0.00% (28.87%) (28.10%) (24.47%)
ROA
4.28% (14.57%) (14.47%) (12.90%)
ROIC
7.46% 0.51% 0.73% 1.37%
Return on Tangible Assets
21.79% (63.25%) (62.71%) (54.08%)
Average Days of Receivables
61.44 59.03 62.73 63.30
Free Cash Flow per Share
3.44 1.22 4.03 0.03
Free Cash Flow
142.73 53.12 178.56 1.45
Other line items

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026